Bladder Cancer Trial, Recruiting NCT06537960 Sponsor: Hopital Foch Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT06537960
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have been diagnosed with muscle-invasive bladder cancer (a specific stage of bladder cancer confirmed by tissue testing) found during a bladder examination procedure
  • People who are already scheduled to have a type of full-body scan called an 18FDG PET-CT at Hôpital Foch
  • People who have signed a consent form agreeing to take part
  • People who are covered by a health insurance scheme

Who may not be able to join:

  • People who have previously had a cancer in the pelvis or urinary/reproductive system
  • People who are known to have cancer that has spread to other parts of the body
  • People for whom the 18FDG PET-CT scan is not medically suitable (confirm with trial site)
  • People who are pregnant or currently breastfeeding
  • People who are under legal guardianship or are not free to make their own decisions (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00 33 1 46 25 11 94

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hopital Foch
Registry
ClinicalTrials.gov
Start date
14 December 2023
Est. completion
15 March 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Sensitivity versus lymph node curage (per side)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov